The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 07, 2012

Filed:

Dec. 29, 2006
Applicants:

Jose Luis Nieva Escandon, Vizcaya, ES;

Maria Jose Gomara Elena, Vizcaya, ES;

Maier Lorizate Nogales, Vizcaya, ES;

Nerea Huarte Arrayago, Vizcaya, ES;

Ismael Mingarro Munoz, Valencia, ES;

Enrique Perez Paya, Valencia, ES;

Inventors:

Jose Luis Nieva Escandon, Vizcaya, ES;

Maria Jose Gomara Elena, Vizcaya, ES;

Maier Lorizate Nogales, Vizcaya, ES;

Nerea Huarte Arrayago, Vizcaya, ES;

Ismael Mingarro Munoz, Valencia, ES;

Enrique Perez Paya, Valencia, ES;

Assignees:

Universidad Del Pais Vasco, Leioa, (Vizcaya), ES;

Universidad de Valencia, Valencia, ES;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61P 31/18 (2006.01); A61K 38/08 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention relates to non-proteolysable oligopeptides that inhibit glycoprotein 41 of the AIDS virus. More specifically, the invention relates to the identification of oligopeptides, particularly hexapeptides, (D), (L) or mixed, preferably D-hexapeptides, which inhibit the binding of a retrovirus to a target cell, thereby providing novel therapies against infection from the human immunodeficiency virus (HIV). The invention also relates to the use of said D-hexapeptides in the form of single components or complex mixtures as prophylactic or therapeutic agents for retroviral infections, especially human immunodeficiency virus type 1 (HIV-1).


Find Patent Forward Citations

Loading…